AU5628380A - Heterocyclic urea derivatives - Google Patents

Heterocyclic urea derivatives

Info

Publication number
AU5628380A
AU5628380A AU56283/80A AU5628380A AU5628380A AU 5628380 A AU5628380 A AU 5628380A AU 56283/80 A AU56283/80 A AU 56283/80A AU 5628380 A AU5628380 A AU 5628380A AU 5628380 A AU5628380 A AU 5628380A
Authority
AU
Australia
Prior art keywords
urea derivatives
heterocyclic urea
heterocyclic
derivatives
urea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56283/80A
Other languages
English (en)
Inventor
Walter Hunkeler
Emilio Kyburz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU5628380A publication Critical patent/AU5628380A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU56283/80A 1979-03-14 1980-03-07 Heterocyclic urea derivatives Abandoned AU5628380A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH241579 1979-03-14
CH241579 1979-03-14
CH17180 1980-01-10
CH17180 1980-01-10

Publications (1)

Publication Number Publication Date
AU5628380A true AU5628380A (en) 1980-09-18

Family

ID=25683737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56283/80A Abandoned AU5628380A (en) 1979-03-14 1980-03-07 Heterocyclic urea derivatives

Country Status (10)

Country Link
EP (1) EP0016371A1 (enExample)
AU (1) AU5628380A (enExample)
DK (1) DK108780A (enExample)
ES (1) ES8103737A1 (enExample)
FI (1) FI800559A7 (enExample)
GR (1) GR66630B (enExample)
IL (1) IL59563A0 (enExample)
MC (1) MC1317A1 (enExample)
NO (1) NO800720L (enExample)
PT (1) PT70949B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
RU2319693C9 (ru) 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
US7838541B2 (en) 2002-02-11 2010-11-23 Bayer Healthcare, Llc Aryl ureas with angiogenesis inhibiting activity
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
PT1580188E (pt) 2002-02-11 2012-01-25 Bayer Healthcare Llc Aril-ureias como inibidores de cinases
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
WO2004113274A2 (en) 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
RS52625B (sr) 2003-07-23 2013-06-28 Bayer Healthcare Llc Fluoro supstituisana omega-karboksiaril difenil urea za lečenje i prevenciju bolesti i stanja bolesti
ATE517885T1 (de) 2004-04-30 2011-08-15 Bayer Healthcare Llc Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448869A1 (de) * 1973-10-19 1975-09-04 Mcneilab Inc 4-oxo-2-imidazolidinylidenharnstoffe, verfahren zu ihrer herstellung und arzneimittel
US3983135A (en) * 1974-09-23 1976-09-28 Mcneil Laboratories, Incorporated 4-Oxo-2-imidazolidinylidene ureas
US4025517A (en) * 1975-06-23 1977-05-24 Mcneil Laboratories, Incorporated 4-Oxo-2-hexahydropyrimidinylidene ureas

Also Published As

Publication number Publication date
PT70949A (en) 1980-04-01
FI800559A7 (fi) 1981-01-01
ES489493A0 (es) 1981-03-16
IL59563A0 (en) 1980-06-30
GR66630B (enExample) 1981-04-03
DK108780A (da) 1980-09-15
ES8103737A1 (es) 1981-03-16
PT70949B (en) 1981-06-24
MC1317A1 (fr) 1981-03-10
EP0016371A1 (de) 1980-10-01
NO800720L (no) 1980-09-15

Similar Documents

Publication Publication Date Title
AU544313B2 (en) Guanidine derivatives
AU6438480A (en) Guanidine derivatives
AU533566B2 (en) Aminoalkylbenzene derivatives
AU538841B2 (en) Quindine derivatives
AU551161B2 (en) Urea derivatives
AU542537B2 (en) Nor-tropane derivatives
AU544515B2 (en) Heterocyclic amino acid derivatives
AU535979B2 (en) 2-imidazoline derivatives
AU516325B2 (en) Spiro-imidazolidinedione derivatives
AU529742B2 (en) Alkyl-ketohexopyranoside derivatives
AU5628380A (en) Heterocyclic urea derivatives
AU534806B2 (en) 3-vinyl-cephalosporin derivatives
AU538138B2 (en) Methylene-cycloamine derivatives
AU533797B2 (en) Thioethylamide derivatives
ZA801151B (en) Heterocyclic derivatives
AU520245B2 (en) Glycerylphosphoryl derivatives
AU526214B2 (en) Pteridin derivatives
AU538139B2 (en) 3-methyleneazetidine derivatives
AU530761B2 (en) Halo-vincamone derivatives
GB2046255B (en) Urea derivatives
AU522936B2 (en) Urea derivatives
AU538087B2 (en) Halophenyl-pyridyl - allylamine derivatives
AU533484B2 (en) Tetrahydrochinoline derivatives
AU538028B2 (en) 1-oxadethiacephalosporin derivatives
AU5515380A (en) Benzamidine derivatives